These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19665226)

  • 1. Epigenetic modifications in AML and MDS.
    Mahmud M; Stebbing J
    Leuk Res; 2010 Feb; 34(2):139-40. PubMed ID: 19665226
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic changes in therapy-related MDS/AML.
    Voso MT; D'Alò F; Greco M; Fabiani E; Criscuolo M; Migliara G; Pagano L; Fianchi L; Guidi F; Hohaus S; Leone G
    Chem Biol Interact; 2010 Mar; 184(1-2):46-9. PubMed ID: 19874806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions.
    Benetatos L; Dasoula A; Hatzimichael E; Syed N; Voukelatou M; Dranitsaris G; Bourantas KL; Crook T
    Ann Hematol; 2011 Sep; 90(9):1037-45. PubMed ID: 21340720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of leukemia and MDS among atomic bomb survivors in Hiroshima and Nagasaki suggests how abnormal epigenetic regulation contributes to leukemogenesis].
    Inaba T
    Rinsho Ketsueki; 2009 Oct; 50(10):1548-52. PubMed ID: 19915365
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methylation status of LINE-1 sequences in patients with MDS or secondary AML].
    Römermann D; Hasemeier B; Metzig K; Schlegelberger B; Länger F; Kreipe H; Lehmann U
    Verh Dtsch Ges Pathol; 2007; 91():338-42. PubMed ID: 18314632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndromes (MDSs) and acute myelogenous leukemia (AML) comprise a closely linked continuum of malignant hematologic diseases. Introduction.
    Baylin SB; Mufti GJ
    Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S1-3. PubMed ID: 16341235
    [No Abstract]   [Full Text] [Related]  

  • 7. Epigenetic signatures as prognostic tools in acute myeloid leukemia and myelodysplastic syndromes.
    Christopeit M; Bartholdy B
    Epigenomics; 2014; 6(4):371-4. PubMed ID: 25333846
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
    Bernasconi P
    Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-quantitative study of calcitonin gene methylation in myelodysplastic syndrome.
    Wu S; Xie G; Bai R; Wang Y; Zhu P
    Chin Med J (Engl); 1998 Aug; 111(8):690-3. PubMed ID: 11245020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of the p15(INK4B) gene in acute leukemia and myelodysplastic syndromes.
    Chen H; Wu S
    Chin Med J (Engl); 2002 Jul; 115(7):987-90. PubMed ID: 12150726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epigenetic dysregulation in myelodysplastic syndrome].
    Sashida G; Iwama A
    Rinsho Ketsueki; 2015 Feb; 56(2):111-8. PubMed ID: 25765789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype.
    Zhang Y; Zhang M; Yang L; Xiao Z
    Leuk Res; 2007 Jan; 31(1):109-11. PubMed ID: 16678898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q.
    Treppendahl MB; Möllgård L; Hellström-Lindberg E; Cloos P; Grønbaek K
    Eur J Haematol; 2013 Mar; 90(3):259-60. PubMed ID: 23190153
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic and epigenetic alterations in myelodysplastic syndrome.
    Mihara K; Takihara Y; Kimura A
    Cytogenet Genome Res; 2007; 118(2-4):297-303. PubMed ID: 18000383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
    Swolin B; Rödjer S; Westin J
    Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distinct genetic pathway in the molecular pathogenesis of MDS/AML with AML1/RUNX1 point mutations].
    Harada H
    Rinsho Ketsueki; 2007 Jul; 48(7):541-6. PubMed ID: 17695302
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of nucleophosmin (NPM) gene mutation in patients with acute myeloid leukemia and myelodysplastic syndromes].
    Zhang Y; Zhang MR; Yang L; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):470-3. PubMed ID: 17147251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in AML.
    Melnick AM
    Best Pract Res Clin Haematol; 2010 Dec; 23(4):463-8. PubMed ID: 21130408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia.
    Karlic H; Herrmann H; Varga F; Thaler R; Reitermaier R; Spitzer S; Ghanim V; Blatt K; Sperr WR; Valent P; Pfeilstöcker M
    Crit Rev Oncol Hematol; 2014 Apr; 90(1):1-16. PubMed ID: 24183913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.